Multiple myeloma (MM) evolves from monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) with annual progression rates of 1% and 10%, respectively. Current risk models don't fully capture the underlying dynamic molecu... ...
